Mechanism of preventive effect of HMG-CoA reductase inhibitor on diabetic nephropathy

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Yokota, Tamotsu ^a   Utsunomiya, Kazunori ^a   Murakawa, Yuichi ^a   Kurata, Hideaki ^a   Tajima, Naoko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes; HMG CoA reductase inhibitor; Provastatin; Ras

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PRAVASTATIN; GLUCOSE; MESSENGER RNA; PROTEIN KINASE (CALCIUM,CALMODULIN); TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; LIPID BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; GENE EXPRESSION; GENETICS; MESANGIUM; METABOLISM; ONCOGENE RAS; WISTAR RAT;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; DIABETIC NEPHROPATHIES; GENE EXPRESSION; GENES, RAS; GLOMERULAR MESANGIUM; GLUCOSE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PRAVASTATIN; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032976297     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. NAKAMURA T, FUKUI M, EBIHARA I, OSADA S, NAGAOKA I, TOMINO Y, KOIDE H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456, 1993
2. SEGAR R, KREBS EG: The MAPK signaling cascade. FASEB J 9:726-735, 1995
3. KYRIAKIS JM, APP H, ZHANG X-H, BANERJEE P, BRAUTIGAN DL, RAPP UR, AVRUCH J: Raf-1 activates MAP kinase-kinase. Nature 358:417-421, 1992
4. HANEDA M, ARAKI S, TOGAWA M, SUGIMOTO T, ISONO M, KIKKAWA R: Mitogen-activated protein kinase cascade is activated in glomer-uli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46:847-853, 1997
5. KURATA H: The preventive effect of an HMG-CoA reductase inhibitor, pravastatin, on diabetic nephropathy in streptozotocin-diabetic rats. Jikeikai Med J 41:219-230, 1994
6. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
7. CASEY PJ, SOLSKI PA, DER CJ, Buss JE: p21Ras is modified by a farnesol isoprenoid. Proc Natl Acad Sci USA 86:8323-8327, 1989
8. O'DONNELL MP KASISKE BL, KIM Y, ATLURU D, KEANE WF: Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest 91:83-87, 1993
9. CHEN D, WATERS SB, HOLT KH, PESSIN JE: Sos phosphorylation and disassociation of the Grb2-Sos complex by the ERK and JNK signaling pathways. J Biol Chem 271:6328-6332, 1996
10. YOKOTA T, UTSUNOMIYA K, KURATA H, TAJIMA N: Contribution of PDGF to expression of TGF-β in the mesangial cells exposed to high glucose (abstract) Diabetes 47 (Suppl 1):A127, 1998